Newly Diagnosed Atrial Fibrillation After Transient Ischemic Attack Versus Minor Ischemic Stroke in the POINT Trial

Background Atrial fibrillation/flutter (AF) after transient ischemic attack (TIA) has not been well studied. We compared the likelihood of new AF diagnosis after ischemic stroke versus TIA. Methods and Results The POINT (Platelet‐Oriented Inhibition in New TIA and Minor Ischemic Stroke) trial enroll...

Full description

Bibliographic Details
Main Authors: Hooman Kamel, Mary Farrant, J. Donald Easton, Luciano A. Sposato, Jordan J. Elm, Ellen Underwood, S. Claiborne Johnston
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.019362
_version_ 1818312237278822400
author Hooman Kamel
Mary Farrant
J. Donald Easton
Luciano A. Sposato
Jordan J. Elm
Ellen Underwood
S. Claiborne Johnston
author_facet Hooman Kamel
Mary Farrant
J. Donald Easton
Luciano A. Sposato
Jordan J. Elm
Ellen Underwood
S. Claiborne Johnston
author_sort Hooman Kamel
collection DOAJ
description Background Atrial fibrillation/flutter (AF) after transient ischemic attack (TIA) has not been well studied. We compared the likelihood of new AF diagnosis after ischemic stroke versus TIA. Methods and Results The POINT (Platelet‐Oriented Inhibition in New TIA and Minor Ischemic Stroke) trial enrolled adults within 12 hours of minor ischemic stroke or high‐risk TIA. Our exposure was index event type (ischemic stroke versus TIA). The primary analysis used the original trial definition of TIA (resolution of symptoms/signs). In secondary analyses, TIA cases with infarction on neuroimaging were reclassified as strokes. Our primary outcome was a new AF diagnosis, ascertained from adverse event and treatment interruption/discontinuation reports. We calculated C‐statistics for variables associated with newly diagnosed AF. We used Kaplan‐Meier survival statistics and Cox models adjusted for demographics and vascular risk factors. Excluding 49 subjects with baseline AF, 2746 patients had index stroke and 2086 patients had index TIA. During the 90‐day follow‐up, 106 patients had newly diagnosed AF. Cumulative risks of AF were 2.7% (95% CI, 2.1%–3.4%) after stroke and 2.0% (95% CI, 1.5%–2.7%) after TIA (P=0.15). After reclassifying index events by neuroimaging, cumulative AF risk was higher after stroke (2.7%; 95% CI, 2.2%–3.4%) than TIA (1.8%; 95% CI, 1.3%–2.5%) (P=0.04). Index event type had negligible predictive utility (C‐statistic, 0.54). Conclusions Among patients with cerebral ischemia, the distinction between TIA versus minor stroke did not stratify the risk of subsequent AF diagnosis, implying that patients with TIA should undergo similar heart‐rhythm monitoring strategies as patients with ischemic stroke.
first_indexed 2024-12-13T08:14:39Z
format Article
id doaj.art-06e1c092ec0545ca8a83427dbb2a41f9
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-12-13T08:14:39Z
publishDate 2021-03-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-06e1c092ec0545ca8a83427dbb2a41f92022-12-21T23:54:09ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802021-03-0110610.1161/JAHA.120.019362Newly Diagnosed Atrial Fibrillation After Transient Ischemic Attack Versus Minor Ischemic Stroke in the POINT TrialHooman Kamel0Mary Farrant1J. Donald Easton2Luciano A. Sposato3Jordan J. Elm4Ellen Underwood5S. Claiborne Johnston6Clinical and Translational Neuroscience Unit Feil Family Brain and Mind Research Institute and Department of Neurology Weill Cornell Medicine New York NYDepartment of Neurology University of California San Francisco CADepartment of Neurology University of California San Francisco CAWestern University London ON CanadaData Coordination Unit Department of Public Health Sciences Medical University of South Carolina Charleston SCData Coordination Unit Department of Public Health Sciences Medical University of South Carolina Charleston SCDean’s Office Dell Medical School University of Texas at Austin Austin TXBackground Atrial fibrillation/flutter (AF) after transient ischemic attack (TIA) has not been well studied. We compared the likelihood of new AF diagnosis after ischemic stroke versus TIA. Methods and Results The POINT (Platelet‐Oriented Inhibition in New TIA and Minor Ischemic Stroke) trial enrolled adults within 12 hours of minor ischemic stroke or high‐risk TIA. Our exposure was index event type (ischemic stroke versus TIA). The primary analysis used the original trial definition of TIA (resolution of symptoms/signs). In secondary analyses, TIA cases with infarction on neuroimaging were reclassified as strokes. Our primary outcome was a new AF diagnosis, ascertained from adverse event and treatment interruption/discontinuation reports. We calculated C‐statistics for variables associated with newly diagnosed AF. We used Kaplan‐Meier survival statistics and Cox models adjusted for demographics and vascular risk factors. Excluding 49 subjects with baseline AF, 2746 patients had index stroke and 2086 patients had index TIA. During the 90‐day follow‐up, 106 patients had newly diagnosed AF. Cumulative risks of AF were 2.7% (95% CI, 2.1%–3.4%) after stroke and 2.0% (95% CI, 1.5%–2.7%) after TIA (P=0.15). After reclassifying index events by neuroimaging, cumulative AF risk was higher after stroke (2.7%; 95% CI, 2.2%–3.4%) than TIA (1.8%; 95% CI, 1.3%–2.5%) (P=0.04). Index event type had negligible predictive utility (C‐statistic, 0.54). Conclusions Among patients with cerebral ischemia, the distinction between TIA versus minor stroke did not stratify the risk of subsequent AF diagnosis, implying that patients with TIA should undergo similar heart‐rhythm monitoring strategies as patients with ischemic stroke.https://www.ahajournals.org/doi/10.1161/JAHA.120.019362arrhythmiaatrial fibrillationatrial flutterischemic stroketransient ischemic attack
spellingShingle Hooman Kamel
Mary Farrant
J. Donald Easton
Luciano A. Sposato
Jordan J. Elm
Ellen Underwood
S. Claiborne Johnston
Newly Diagnosed Atrial Fibrillation After Transient Ischemic Attack Versus Minor Ischemic Stroke in the POINT Trial
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
arrhythmia
atrial fibrillation
atrial flutter
ischemic stroke
transient ischemic attack
title Newly Diagnosed Atrial Fibrillation After Transient Ischemic Attack Versus Minor Ischemic Stroke in the POINT Trial
title_full Newly Diagnosed Atrial Fibrillation After Transient Ischemic Attack Versus Minor Ischemic Stroke in the POINT Trial
title_fullStr Newly Diagnosed Atrial Fibrillation After Transient Ischemic Attack Versus Minor Ischemic Stroke in the POINT Trial
title_full_unstemmed Newly Diagnosed Atrial Fibrillation After Transient Ischemic Attack Versus Minor Ischemic Stroke in the POINT Trial
title_short Newly Diagnosed Atrial Fibrillation After Transient Ischemic Attack Versus Minor Ischemic Stroke in the POINT Trial
title_sort newly diagnosed atrial fibrillation after transient ischemic attack versus minor ischemic stroke in the point trial
topic arrhythmia
atrial fibrillation
atrial flutter
ischemic stroke
transient ischemic attack
url https://www.ahajournals.org/doi/10.1161/JAHA.120.019362
work_keys_str_mv AT hoomankamel newlydiagnosedatrialfibrillationaftertransientischemicattackversusminorischemicstrokeinthepointtrial
AT maryfarrant newlydiagnosedatrialfibrillationaftertransientischemicattackversusminorischemicstrokeinthepointtrial
AT jdonaldeaston newlydiagnosedatrialfibrillationaftertransientischemicattackversusminorischemicstrokeinthepointtrial
AT lucianoasposato newlydiagnosedatrialfibrillationaftertransientischemicattackversusminorischemicstrokeinthepointtrial
AT jordanjelm newlydiagnosedatrialfibrillationaftertransientischemicattackversusminorischemicstrokeinthepointtrial
AT ellenunderwood newlydiagnosedatrialfibrillationaftertransientischemicattackversusminorischemicstrokeinthepointtrial
AT sclaibornejohnston newlydiagnosedatrialfibrillationaftertransientischemicattackversusminorischemicstrokeinthepointtrial